“In full awareness and in full anguish”, titre Kommersant to accompany the latest publication from the Russian federal statistics agency, Rosstat, on the mental health of Russians. Between 2020 and 2024, diagnoses of depression, anxiety disorders or stress jumped by 21.5% in Russia. More broadly, non-psychotic mental disorders now affect 341,400 people, compared to 281,000 four years earlier. And the figures for 2025 look just as worrying. “The dynamic does not weaken”, summarizes the Russian economic daily.
In the absence of official data for 2025, sales of antidepressants are enough, writes Kommersant. Last year, 23.6 million boxes were sold in Russian pharmacies, according to calculations by RNC Pharma, a firm specializing in pharmaceutical market analysis. That’s 24% more than the previous year, and almost twice as much as in 2022. During the first two weeks of January 2026 alone, “already a million boxes [ont été] elapsed”, an increase of 18% compared to the same period last year, detailed RBK.
An analysis company, DSM Group, cited by this economic media, estimates that pharmacies have earned 20.5 billion rubles, or approximately 226 million euros, on these products.
date: 2026-02-07 04:03:00